Rrp6 inhibitors represent a class of chemical compounds designed to selectively target and modulate the activity of the Rrp6 protein. Rrp6, also known as Rat1 in yeast, is an essential component of the RNA exosome complex, which is responsible for RNA processing and degradation in eukaryotic cells. This protein complex plays a crucial role in maintaining RNA quality control, regulating the turnover of various RNA species, including ribosomal RNA (rRNA), messenger RNA (mRNA), and small non-coding RNAs. Rrp6 inhibitors serve as invaluable tools in molecular biology and cellular research, allowing scientists to investigate the intricate roles of Rrp6 in RNA metabolism and the mechanisms underlying RNA processing and degradation.
Researchers use Rrp6 inhibitors to explore the specific functions of Rrp6 within the RNA exosome complex. By selectively inhibiting Rrp6, scientists can examine its interactions with other exosome components, its role in RNA degradation pathways, and its contributions to the surveillance and quality control of RNA molecules. This research aids in unraveling the molecular processes that govern the stability and turnover of various RNA species, ultimately contributing to our understanding of gene expression regulation and the maintenance of cellular RNA homeostasis. Additionally, the study of Rrp6 inhibitors has broader implications for elucidating the mechanisms of RNA processing and turnover in eukaryotic cells, offering insights into the complex network of pathways that shape the RNA landscape and its impact on cellular functions. In summary, Rrp6 inhibitors serve as essential tools for unraveling the molecular intricacies of RNA metabolism and RNA quality control, enhancing our understanding of cellular processes related to gene expression and RNA stability.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound intercalates into DNA and prevents RNA synthesis by RNA polymerase, potentially leading to reduced Rrp6 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
A potent inhibitor of RNA polymerase II; it could decrease transcription levels of Rrp6 mRNA. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Known to inhibit bacterial RNA polymerase; in eukaryotes, it might influence RNA pol I and III, indirectly affecting Rrp6 levels. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
It inhibits transcriptional activity by affecting RNA polymerase II, possibly reducing Rrp6 mRNA synthesis. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin is an adenosine analog that disrupts RNA synthesis and could lead to decreased levels of Rrp6 mRNA. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits RNA polymerase II phosphorylation, potentially reducing Rrp6 expression. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
This compound inhibits nuclear export, which could lead to indirect effects on Rrp6 mRNA levels and stability. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
By depleting guanine nucleotides, this compound could indirectly reduce transcription of Rrp6. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
As a nucleotide analog, it may incorporate into RNA, potentially affecting Rrp6 mRNA stability and levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis, potentially leading to a decrease in Rrp6 protein levels indirectly by blocking translation. | ||||||